134 related articles for article (PubMed ID: 9054615)
1. Expression of estrogen receptors in a normal human breast epithelial cell type with luminal and stem cell characteristics and its neoplastically transformed cell lines.
Kang KS; Morita I; Cruz A; Jeon YJ; Trosko JE; Chang CC
Carcinogenesis; 1997 Feb; 18(2):251-7. PubMed ID: 9054615
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor variants in normal human mammary tissue.
Leygue ER; Watson PH; Murphy LC
J Natl Cancer Inst; 1996 Mar; 88(5):284-90. PubMed ID: 8614007
[TBL] [Abstract][Full Text] [Related]
3. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
Morrissey JJ; Raney S
Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
[TBL] [Abstract][Full Text] [Related]
4. Classification of breast cancer cells on the basis of a functional assay for estrogen receptor.
Biswas DK; Averboukh L; Sheng S; Martin K; Ewaniuk DS; Jawde TF; Wang F; Pardee AB
Mol Med; 1998 Jul; 4(7):454-67. PubMed ID: 9713824
[TBL] [Abstract][Full Text] [Related]
5. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line.
Castles CG; Fuqua SA; Klotz DM; Hill SM
Cancer Res; 1993 Dec; 53(24):5934-9. PubMed ID: 8261406
[TBL] [Abstract][Full Text] [Related]
6. Growth requirements and neoplastic transformation of two types of normal human breast epithelial cells derived from reduction mammoplasty.
Kao CY; Oakley CS; Welsch CW; Chang CC
In Vitro Cell Dev Biol Anim; 1997 Apr; 33(4):282-8. PubMed ID: 9156344
[TBL] [Abstract][Full Text] [Related]
7. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor.
Zajchowski DA; Sager R; Webster L
Cancer Res; 1993 Oct; 53(20):5004-11. PubMed ID: 8402691
[TBL] [Abstract][Full Text] [Related]
8. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer.
Daffada AA; Johnston SR; Smith IE; Detre S; King N; Dowsett M
Cancer Res; 1995 Jan; 55(2):288-93. PubMed ID: 7812959
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor variants in epithelial compartment of normal human breast.
Yang J; Liu A; Guzman R; Nandi S
Endocrine; 2000 Jun; 12(3):243-7. PubMed ID: 10963044
[TBL] [Abstract][Full Text] [Related]
10. Ribozyme-mediated down-regulation of ErbB-4 in estrogen receptor-positive breast cancer cells inhibits proliferation both in vitro and in vivo.
Tang CK; Concepcion XZ; Milan M; Gong X; Montgomery E; Lippman ME
Cancer Res; 1999 Oct; 59(20):5315-22. PubMed ID: 10537315
[TBL] [Abstract][Full Text] [Related]
11. Coexpression of wild-type and variant oestrogen receptor mRNAs in a panel of human breast cancer cell lines.
Castles CG; Klotz DM; Fuqua SA; Hill SM
Br J Cancer; 1995 May; 71(5):974-80. PubMed ID: 7734323
[TBL] [Abstract][Full Text] [Related]
12. Modulation of tumorigenesis and oestrogen receptor-alpha expression by cell culture conditions in a stem cell-derived breast epithelial cell line.
Wang KH; Kao AP; Chang CC; Lee JN; Chai CY; Hou MF; Liu CM; Tsai EM
Biol Cell; 2010 Jan; 102(3):159-72. PubMed ID: 19895368
[TBL] [Abstract][Full Text] [Related]
13. Expression of estrogen receptor beta messenger RNA variant in breast cancer.
Vladusic EA; Hornby AE; Guerra-Vladusic FK; Lupu R
Cancer Res; 1998 Jan; 58(2):210-4. PubMed ID: 9443393
[TBL] [Abstract][Full Text] [Related]
14. Expression of an estrogen receptor alpha variant protein in cell lines and tumors.
Fasco MJ; Keyomarsi K; Arcaro KF; Gierthy JF
Mol Cell Endocrinol; 2000 Apr; 162(1-2):167-80. PubMed ID: 10854710
[TBL] [Abstract][Full Text] [Related]
15. Expression of an estrogen receptor alpha variant protein in cell lines and tumors.
Fasco MJ; Keyomarsi K; Arcaro KF; Gierthy JF
Mol Cell Endocrinol; 2000 Aug; 166(2):156-69. PubMed ID: 11203301
[TBL] [Abstract][Full Text] [Related]
16. Two types of normal human breast epithelial cells derived from reduction mammoplasty: phenotypic characterization and response to SV40 transfection.
Kao CY; Nomata K; Oakley CS; Welsch CW; Chang CC
Carcinogenesis; 1995 Mar; 16(3):531-8. PubMed ID: 7697810
[TBL] [Abstract][Full Text] [Related]
17. Expression and cellular localization of naturally occurring beta estrogen receptors in uterine and mammary cell lines.
Monje P; Boland R
J Cell Biochem; 2002; 86(1):136-44. PubMed ID: 12112024
[TBL] [Abstract][Full Text] [Related]
18. Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer.
Fuqua SA; Schiff R; Parra I; Friedrichs WE; Su JL; McKee DD; Slentz-Kesler K; Moore LB; Willson TM; Moore JT
Cancer Res; 1999 Nov; 59(21):5425-8. PubMed ID: 10554010
[TBL] [Abstract][Full Text] [Related]
19. Induction of 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13.
Gingras S; Moriggl R; Groner B; Simard J
Mol Endocrinol; 1999 Jan; 13(1):66-81. PubMed ID: 9892013
[TBL] [Abstract][Full Text] [Related]
20. The histone methyltransferase EZH2 promotes mammary stem and luminal progenitor cell expansion, metastasis and inhibits estrogen receptor-positive cellular differentiation in a model of basal breast cancer.
Wu J; Crowe DL
Oncol Rep; 2015 Jul; 34(1):455-60. PubMed ID: 25998860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
